A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

RECRUITING

Concord Repatriation General Hospital /ID# 249240, Concord

RECRUITING

St Vincent's Hospital Melbourne /ID# 247624, Fitzroy Melbourne

RECRUITING

One Clinical Research Pty Ltd /ID# 248392, Nedlands

RECRUITING

Hospital Universitario Fundación Jiménez Díaz /ID# 265198, Madrid

RECRUITING

Novant Health Presbyterian Medical Center /ID# 246719, Charlotte

COMPLETED

Sylvester Comprehensive Cancer Center - University of Miami /ID# 247232, Miami

RECRUITING

Hospital Universitario Marques de Valdecilla /ID# 262826, Santander

RECRUITING

University of Nebraska Medical Center /ID# 246715, Omaha

RECRUITING

Baylor Sammons Cancer Center /ID# 247715, Dallas

RECRUITING

University of Texas Health San Antonio MD Anderson Cancer Center /ID# 256234, San Antonio

RECRUITING

University of Arizona Cancer Center - Tucson /ID# 247752, Tucson

RECRUITING

Hadassah Medical Center-Hebrew University /ID# 254885, Jerusalem

RECRUITING

The Chaim Sheba Medical Center /ID# 254884, Ramat Gan

RECRUITING

Allina Health System /ID# 251782, Minneapolis

RECRUITING

Memorial Sloan Kettering Cancer Center-Koch Center /ID# 249246, New York

RECRUITING

Cross Cancer Institute /ID# 246717, Edmonton

RECRUITING

University Health Network_Princess Margaret Cancer Centre /ID# 243936, Toronto

RECRUITING

Seoul National University Hospital /ID# 263945, Seoul

RECRUITING

Asan Medical Center /ID# 263220, Seoul

RECRUITING

Samsung Medical Center /ID# 263294, Seoul